EDGEWELL PERSONAL CARE Co

Listed Company

EPCCIK 0001096752NYSELarge AcceleratedPerfumes, Cosmetics & Other Toilet PreparationsMissouriFY ends Sep 30

Period

FY 2025

Revenue

$2.22B

Net Income

$25.40M

Total Assets

$3.76B

Equity

$1.55B

Shares Out

46.72M

Op. Cash Flow

$118.40M

Business

EDGEWELL PERSONAL CARE Co manufactures and markets personal care products across the Wet Shave, Sun and Skin Care, and Feminine Care categories. It offers branded and private‑label razors, blades and shaving preparations; sun care and skin care products; men’s grooming and skincare lines; antibacterial wipes; and feminine hygiene products such as tampons, pads and liners. The company reports three operating segments—Wet Shave, Sun and Skin Care, and Feminine Care—and includes direct‑to‑consumer and private‑label businesses. Products are sold in over 50 countries through direct sales teams, retailers, wholesalers, e‑commerce and third‑party distributors, with primary markets including the U.S., Canada, Japan and major Western European markets.

Summary from filing dated 2025-11-18

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30
Net sales	2,224	2,254	2,252	2,172	2,087
Cost of products sold	1,299	1,298	1,311	1,291	1,136
Gross profit	925	956	941	881	951
Selling, general and administrative expense	425	430	410	—	—
Advertising and sales promotion expense	247	232	229	238	242
Research and development expense	58	58	59	56	58
Restructuring charges	48	36	17	15	21
Goodwill, Impairment Loss	51	—	—	—	—
Operating income	97	199	227	182	240
Interest expense associated with debt	73	77	79	71	68
Other (income) expense, net	−200,000	2	800,000	−13	−1
Earnings before income taxes	24	121	148	124	147
Income tax (benefit) provision	−2	22	33	25	29
Net earnings	25	99	115	100	118
Basic	0.53	1.98	2.24	1.87	2.17
Diluted	0.53	1.97	2.21	1.85	2.13
Foreign currency translation adjustments	27	19	44	−89	6
Pension and postretirement activity, net of tax	17	1	7	5	45
Deferred gain (loss) on hedging activity, net of tax	800,000	−5	−5	6	4
Total other comprehensive income (loss), net of tax	45	15	46	−79	55
Total comprehensive income	70	114	161	20	173
Basic weighted-average shares outstanding (in shares)	48	50	51	—	—
Diluted weighted-average shares outstanding (in shares)	48	50	52	—	—

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30
Cash and cash equivalents	226	209	216	189	—
Trade receivables	138	109	106	137	151
Inventory, Net	485	477	492	449	346
Other current assets	147	140	147	167	160
Total current assets	996	936	962	942	1,136
Property, Plant and Equipment, Net	369	349	338	346	363
Goodwill	1,291	1,339	1,331	1,322	1,163
Other intangible assets, net	921	949	974	997	906
Other assets	179	159	135	107	107
Total assets	3,756	3,731	3,741	3,713	3,675
Notes payable	30	25	20	19	27
Accounts payable	220	219	194	229	210
Other current liabilities	316	320	310	292	301
Total current liabilities	566	564	523	540	537
Long-term debt	1,383	1,275	1,361	1,391	1,234
Deferred income tax liabilities	119	133	136	140	129
Other liabilities	136	175	180	175	190
Total liabilities	2,203	2,147	2,200	2,246	2,090
Common shares	700,000	700,000	700,000	700,000	700,000
Additional paid-in capital	1,579	1,586	1,594	1,604	1,631
Retained earnings	1,087	1,090	1,022	939	866
Common shares in treasury at cost	−1,003	−938	−906	−861	−776
Accumulated other comprehensive loss	−110	−155	−170	−216	−137
Total shareholders equity	1,553	1,584	1,541	1,467	1,591
Total liabilities and shareholders equity	3,756	3,731	3,741	3,713	3,675
Common shares, par value (in usd per share)	0.01	0.01	0.01	0.01	0.01
Common shares, issued (in shares)	65	65	65	65	65
Common shares, authorized (in shares)	300	300	300	300	300
Treasury shares (in shares)	19	16	15	14	—
Preferred shares, authorized (in shares)	10	10	10	10	10
Preferred shares, par value (in usd per share)	0.01	0.01	0.01	0.01	0.01
Preferred shares, outstanding (in shares)	0	0	0	0	0

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30
Depreciation, Depletion and Amortization	89	88	91	90	87
Share-based compensation expense	25	27	28	24	27
Deferred income taxes	−22	−10	−5	−14	10
Deferred compensation payments	−3	−2	−5	−7	−9
Defined benefit settlement loss	2	700,000	3	2	900,000
Defined benefit settlement loss	0	0	−8	0	0
Other, net	−23	−19	−24	−10	−3
Increase (Decrease) in Accounts Receivable	15	7	−31	−7	4
Increase (Decrease) in Inventories	100,000	20	−32	−111	−29
Increase (Decrease) in Other Current Assets	3	−5	−21	−12	−14
Increase (Decrease) in Accounts Payable, Trade	3	17	−30	29	24
Increase (Decrease) in Other Current Liabilities	−11	14	16	18	−13
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation, Total	118	−231	−216	102	229
Payments to Acquire Productive Assets	77	57	50	−56	−57
Proceeds from Collection of Retained Interest in Securitized Receivables	6	700,000	3	7	3
Payment for (Proceeds from) Other Investing Activity	2	−7	−4	−2	−2
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation, Total	−73	−62	−51	−355	−49
Proceeds from Long-Term Lines of Credit	931	813	841	707	0
Repayments of Long-Term Lines of Credit	825	901	874	−552	0
Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less	6	4	0	−4	4
Payments for Repurchase of Common Stock	90	59	75	−125	−9
Payments of Dividends	29	31	32	−33	−26
Payment, Tax Withholding, Share-Based Payment Arrangement	8	7	9	−11	−4
Proceeds from (Repayments of) Accounts Receivable Securitization	−14	5	2	−800,000	2
Other, net	−400,000	−4	−100,000	700,000	−400,000
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation, Total	−30	−179	−147	−18	−65
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation	1	4	9	−20	−400,000
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation, Total	17	−7	28	−291	115
Cash paid for interest, net	73	63	74	68	61
Cash paid for income taxes, net	26	34	46	24	25

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro